Pierre Fabre Medicament Plantes And Industrie, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for The 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group.
One of their notable products is MILNACIPRAN HYDROCHLORIDE (PROCESS II), with a corresponding US DMF Number 24073.
Remarkably, this DMF maintains an Inactive status since its submission on June 30, 2010, highlighting commitment to regulatory compliance.